References
- Nicholson MJ, Manley C, Ahmad D. Thoracentesis for the diagnosis and management of pleural effusions: the current state of a centuries-old procedure. Journal of Respiration. 2023;3(4): 208–222. doi:10.3390/jor3040020
- Krishna R, Antoine MH, Alahmadi MH, Rudrappa M. Pleural effusion. 2025.
- Jarvis B, Simpson K. Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs. 2000;60(2): 347–377. doi:10.2165/00003495-200060020-00012
- Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. Journal of Vascular and Interventional Radiology. 2012;23(6): 727–736. doi:10.1016/j. jvir.2012.02.012
- Perl S, Bondarenco M, Natif N, Shpirer Y, Enghelberg S, Fox B. Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study. Respiratory Research. 2020;21(1): 281. doi:10.1186/s12931-020-01549-z
- DeBiasi EM, Puchalski J. Thoracentesis: state-of-the-art in procedural safety, patient outcomes, and physiologic impact. PLEURA. 2016;3. doi:10.1177/2373997516646554
- Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115(6): 813–818. doi:10.1161/CIRCULATIONAHA.106.180944
- Irugulapati L, George J, Weingarten J, Sethi S. Is it safe to perform thoracentesis while taking clopidogrel? Chest. 2012;142(4): 524A. doi:10.1378/chest.1387111
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.). 2021;372: n71. doi:10.1136/bmj.n71
- Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Accessed: 8th July 2025]
- Borges Migliavaca C, Stein C, Colpani V, Barker TH, Munn Z, Falavigna M, et al. How are systematic reviews of prevalence conducted? A methodological study. BMC Medical Research Methodology. 2020;20(1): 96. doi:10.1186/s12874-020-00975-3
- Lin L, Xu C, Chu H. Empirical comparisons of 12 meta-analysis methods for synthesizing proportions of binary outcomes. Journal of General Internal Medicine. 2022;37(2): 308–317. doi:10.1007/s11606-021-07098-5
- Abdulmajeed J, Chivese T, Doi SAR. Overcoming challenges in prevalence meta-analysis: the case for the Freeman-Tukey transform. BMC Medical Research Methodology. 2025;25(1): 89. doi:10.1186/s12874-025-02527-z
- Freeman MF, Tukey JW. Transformations related to the angular and the square root. The Annals of Mathematical Statistics. 1950;21(4): 607–611. doi:10.1214/aoms/1177729756
- Mahmood K, Shofer SL, Moser BK, Argento AC, Smathers EC, Wahidi MM. Hemorrhagic complications of thoracentesis and small-bore chest tube placement in patients taking clopidogrel. Annals of the American Thoracic Society. 2014;11(1): 73–79. doi:10.1513/AnnalsATS.201303-050OC
- Aljundi L, Chaar A, Boshara P, Shiari A, Gennaoui G, Noori Z, et al. Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis. BMJ Open Respiratory Research. 2021;8(1): e000874. doi:10.1136/bmjresp-2021-000874
- Patel PP, Singh S, Atwell TD, Kashyap R, Kern RM, Mullon JJ, et al. The safety of ultrasound-guided thoracentesis in patients on novel oral anticoagulants and clopidogrel: a single-center experience. Mayo Clinic Proceedings. 2019;94(8): 1535–1541. doi:10.1016/j.mayocp.2019.01.046
- Puchalski JT, Argento AC, Murphy TE, Araujo KLB, Pisani MA. The safety of thoracentesis in patients with uncorrected bleeding risk. Annals of the American Thoracic Society. 2013;10(4): 336–341. doi:10.1513/AnnalsATS.201210-088OC
- Dammert P, Pratter M, Boujaoude Z. Safety of ultrasound-guided small-bore chest tube insertion in patients on clopidogrel. Journal of Bronchology and Interventional Pulmonology. 2013;20(1): 16–20. doi:10.1097/LBR.0b013e31828194f9
- Zalt MB, Bechara RI, Parks C, Berkowitz DM. Effect of routine clopidogrel use on bleeding complications after ultrasound-guided thoracentesis. Journal of Bronchology and Interventional Pulmonology. 2012;19(4): 284–287. doi:10.1097/LBR.0b013e3182720428
- Abouzgheib W, Shweihat YR, Meena N, Bartter T. Is chest tube insertion with ultrasound guidance safe in patients using clopidogrel? Respirology (Carlton, Vic.). 2012;17(8): 1222–1224. doi:10.1111/j.1440-1843.2012.02230.x
- Sisniega CF, Kheir F, Alamro S, Chee AC, Parikh MS, Majid A. Bleeding in patients undergoing indwelling pleural catheters while on antiplatelet therapy. American Journal of Respiratory and Critical Care Medicine. 2019: 199–199.
- Salguero BD, Rothman A, Shujaat A. To hold or not to hold clopidogrel prior to ultrasound-guided thoracentesis. American Journal of Respiratory and Critical Care Medicine. 2019: 199–199.
- Parks C, Brown MA, Bechara R, Ross C. Safety of plavix during thoracentesis. American Journal of Respiratory and Critical Care Medicine. 2010: 181–181.
- Gordon CE, Feller-Kopman D, Balk EM, Smetana GW. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Archives of Internal Medicine. 2010;170(4): 332–339. doi:10.1001/archinternmed.2009.548
- Herman DD, Thomson CC, Brosnhan S, Patel R, Trosini-Desert V, Bilaceroglu S, et al. Risk of bleeding in patients undergoing pulmonary procedures on antiplatelet or anticoagulants: a systematic review. Respiratory Medicine. 2019;153: 76–84. doi:10.1016/j.rmed.2019.05.018
- Fong C, Tan CWC, Tan DKY, See KC. Safety of thoracentesis and tube thoracostomy in patients with uncorrected coagulopathy: a systematic review and meta-analysis. Chest. 2021;160(5): 1875–1889. doi:10.1016/j.chest.2021.04.036
- Adityawan YC, Al Mubarok T. The analysis study of risk of bleeding in patients undergoing pulmonary procedure on antiplatelet or anticoagulant: a comprehensive systematic review. The International Journal of Medical Science and Health Research. 2024;4(1). doi:10.70070/jnha0290
- Godfrey M, Puchalski J. Pleural effusions in the critically ill and ‘at-bleeding-risk’ population. Clinics in Chest Medicine. 2021;42(4): 677–686. doi:10.1016/j.ccm.2021.08.012
- Pathak V, Allender JE, Grant MW. Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures. European Respiratory Review: An Official Journal of the European Respiratory Society. 2017;26(145): 170020. doi:10.1183/16000617.0020-2017
- Linder K, Epelbaum O. Percutaneous pleural drainage in patients taking clopidogrel: real danger or phantom fear? Journal of Thoracic Disease. 2018;10(8): 5162–5169. doi:10.21037/jtd.2018.04.161
- DeBiasi EM, Murphy TE, Araujo KLB, Pisani MA, Puchalski JT. Physician practice patterns for performing thoracentesis in patients taking anticoagulant medications. Journal of Bronchology and Interventional Pulmonology. 2020;27(1): 42–49. doi:10.1097/LBR.0000000000000614